Intravenous renal cell transplantation with SAA1-positive cells prevents the progression of chronic renal failure in rats with ischemic-diabetic nephropathy

American Journal of Physiology - Renal Physiology

Volumn 305, Issue 12, 2013, Pages

  Kelly, Katherine J ^a   Zhang, Jizhong ^a   Han, Ling ^a   Wang, Mingsheng ^a   Zhang, Shaobo ^a   Dominguez, Jesus H ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Chronic renal failure; Diabetic nephropathies; Organ regeneration; Serum amyloid A

Indexed keywords

SERUM AMYLOID A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CLAMP; ARTICLE; CELL STRUCTURE; CELL TRANSPLANTATION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE SEVERITY; FEMALE; GLOMERULUS; IMMUNOHISTOCHEMISTRY; INFUSION; INTRAVENOUS RENAL CELL TRANSPLANTATION; KIDNEY CELL; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TUBULE; KIDNEY TUBULE CELL; MALE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL ARTERY; THERAPY EFFECT;

CHRONIC RENAL FAILURE; DIABETIC NEPHROPATHIES; ORGAN REGENERATION; SERUM AMYLOID A;

ADMINISTRATION, INTRAVENOUS; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; ISCHEMIA; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; OBESITY; RATS; RATS, ZUCKER; SERUM AMYLOID A PROTEIN; TRANSPLANTS; TREATMENT OUTCOME;

EID: 84890377276     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00097.2013     Document Type: Article

References (33)

1. Caldas HC, Hayashi AP, Abbud-Filho M. Repairing the chronic damaged kidney: the role of regenerative medicine. Transplant Proc 43: 3573-3576, 2011.
2. Duffield JS, Park KM, Hsiao LL, Kelley VR, Scadden DT, Ichimura T, Bonventre JV. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 115: 1743-1755, 2005.
3. Ebrahimi B, Li Z, Eirin A, Zhu XY, Textor SC, Lerman LO. Addition of endothelial progenitor cells to renal revascularization restores medullary tubular oxygen consumption in swine renal artery stenosis. Am J Physiol Renal Physiol 302: F1478-F1485, 2012.
4. Feng Z, Ting J, Alfonso Z, Strem BM, Fraser JK, Rutenberg J, Kuo HC, Pinkernell K. Fresh and cryopreserved, uncultured adipose tissue-derived and regenerative cells ameliorate ischemia-reperfusion-induced acute kidney injury. Nephrol Dial Transplant 25: 3874-3884, 2010.
5. Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic renal disease: more than an aftermath of glomerular injury? Kidney Int 56: 1627-1637, 1999.
6. Guo JK, Cantley LG. Cellular maintenance and repair of the kidney. Annu Rev Physiol 72: 357-376, 2010.
7. Hauser PV, De Fazio R, Bruno S, Sdei S, Grange C, Bussolati B, Benedetto C, Camussi G. Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery. Am J Pathol 177: 2011-2021, 2010.
8. Hendry CE, Little MH. Reprogramming the kidney: a novel approach for regeneration. Kidney Int 82: 138-146, 2012.
9. Himmelfarb J, Ikizler TA. Hemodialysis. N Engl J Med 363: 1833-1845, 2010.
10. Hsu CY. Where is the epidemic in kidney disease? J Am Soc Nephrol 21: 1607-1611, 2010.
11. Kale S, Karihaloo A, Clark PR, Kashgarian M, Krause DS, Cantley LG. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest 112: 42-49, 2003.
12. Kelly KJ, Burford JL, Dominguez JH. Post-ischemic inflammatory syndrome: a critical mechanism of progression in diabetic nephropathy. Am J Physiol Renal Physiol 297: F923-F931, 2009.
13. Kelly KJ, Dominguez JH. Rapid progression of diabetic nephropathy is linked to inflammation and episodes of acute renal failure. Am J Nephrol 32: 469-475, 2010.
14. Kelly KJ, Dominguez JH. Treatment of the post-ischemic inflammatory syndrome of diabetic nephropathy. Nephrol Dial Transplant 25: 3204-3212, 2010.
15. Kelly KJ, Kluve-Beckerman B, Dominguez JH. Acute-phase response protein serum amyloid A stimulates renal tubule formation: studies in vitro and in vivo. Am J Physiol Renal Physiol 296: F1355-F1363, 2009.
16. Kelly KJ, Kluve-Beckerman B, Zhang J, Dominguez JH. Intravenous cell therapy for acute renal failure with serum amyloid A protein-repro-grammed cells. Am J Physiol Renal Physiol 299: F453-F464, 2010.
17. Kelly KJ, Liu Y, Zhang J, Goswami C, Lin H, Dominguez JH. Comprehensive genomic profiling in diabetic nephropathy reveals predominance of proinflammatory pathways. Physiol Genomics 45: 710-719, 2013.
18. Kelly KJ, Williams WW Jr, Colvin RB, Bonventre JV. Antibody to intracellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA 91: 812-816, 1994.
19. Kelly KJ, Zhang J, Wang M, Zhang S, Dominguez JH. Intravenous renal cell transplantation for rats with acute and chronic renal failure. Am J Physiol Renal Physiol 303: F357-F365, 2012.
20. Kunter U, Rong S, Boor P, Eitner F, Muller-Newen G, Djuric Z, van Roeyen CR, Konieczny A, Ostendorf T, Villa L, Milovanceva-Pop-ovska M, Kerjaschki D, Floege J. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol 18: 1754-1764, 2007.
21. Lin F, Moran A, Igarashi P. Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest 115: 1756-1764, 2005.
22. Lindenmeyer MT, Kretzler M, Boucherot A, Berra S, Yasuda Y, Henger A, Erichinger F, Gaiser S, Schmid H, Rastaldi MP, Schrier RW, Schlondorff D, Cohen CD. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol 18: 1765-1776, 2007.
23. National Institute of Diabetes and Digestive and Kidney Diseases. United States Renal Data System. 2010 Annual Data Report. Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, 2010, vol. 1.
24. Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG; DEMAND Investigators. Prevalence and risk factors for microalbumin-uria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 69: 2057-2063, 2006.
25. Ritz E, Zeng XX, Rychlik I. Clinical manifestations and natural history of diabetic nephropathy. Contrib Nephrol 170: 19-27, 2011.
26. Seckert CK, Renzaho A, Tervo HM, Krause C, Deegen P, Kuhnapfel B, Reddehase MJ, Grzimek NK. Liver sinusoidal endothelial cells are a site of murine cytomegalovirus latency and reactivation. J Virol 83: 8869-8884, 2009.
27. Spiel AO, Gilbert JC, Jilma B. von Williebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation 117: 1449-1459, 2008.
28. Temm C, Dominguez JH. Microcirculation: nexus of comorbidities in diabetes. Am J Physiol Renal Physiol 293: F486-F493, 2007.
29. Thakar CV, Christianson A, Himmelfarb J, Leonard AC. Acute kidney injury episodes and chronic kidney disease risk in diabetes melli-tus. Clin J Am Soc Nephrol 6: 2567-2572, 2011.
30. Togel F, Isaac J, Hu Z, Weiss K, Westenfelder C. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 67: 1772-1784, 2005.
31. Uzu T, Kida Y, Shirahashi N, Harada T, Yamauchi A, Nomura M, Isshiki K, Araki S, Sugimoto T, Koya D, Haneda M, Kashiwagi A, Kikkawa R. Cerebral microvascular disease predicts renal failure in type 2 diabetes. J Am Soc Nephrol 21: 520-526, 2010.
32. Venkatachalam MA, Griffin KA, Lan R, Geng H, Saikumar P, Bidani AK. Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol 298: F1078-F1094, 2010.
33. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LYC, Held PJ, Port FK. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341: 1725-1730, 1993.